单位:[1]Department of Gynecology and Obstetrics,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei,China妇产科学系华中科技大学同济医学院附属同济医院普通妇科
This work was supported by the National Key Technology Research
and Development Program of China [grant numbers 2022YFC2704400,
2022YFC2704403, and 2022YFC2702504]; the National Clinical
Research Center of Obstetrics and Gynecology [grant number
2015BAI13B05]; and the National Natural Science Foundation of China
[grant number 82101700].
第一作者单位:[1]Department of Gynecology and Obstetrics,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei,China
通讯作者:
通讯机构:[1]Department of Gynecology and Obstetrics,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei,China[*1]Department of Gynecology and Obstetrics,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,1095 Jiefang Blvd,Wuhan 430030,China
推荐引用方式(GB/T 7714):
Guo Shuaiqingying,Yuan Jing,Meng Xiaolin,et al.Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?[J].INTERNATIONAL IMMUNOPHARMACOLOGY.2023,122:doi:10.1016/j.intimp.2023.110601.
APA:
Guo Shuaiqingying,Yuan Jing,Meng Xiaolin,Feng Xue,Ma Ding...&Li Kezhen.(2023).Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?.INTERNATIONAL IMMUNOPHARMACOLOGY,122,
MLA:
Guo Shuaiqingying,et al."Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?".INTERNATIONAL IMMUNOPHARMACOLOGY 122.(2023)